{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:02:50Z","timestamp":1771056170942,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-026-02787-z","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T15:14:45Z","timestamp":1768058085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of timing of post-operative radiation on outcomes in anaplastic thyroid cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Andrew B.","family":"Bonner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon A.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Willey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Kole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"2787_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jss.2022.11.033","volume":"283","author":"A Bonner","year":"2003","unstructured":"Bonner A, et al. The association of socioeconomic factors and well-differentiated thyroid cancer. J Surg Res. 2023;283:973\u201381. https:\/\/doi.org\/10.1016\/j.jss.2022.11.033.","journal-title":"J Surg Res"},{"key":"2787_CR2","first-page":"5888","volume":"11","author":"B Lin","year":"2019","unstructured":"Lin B, et al. The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis. Am J Transl Res. 2019;11:5888\u201396.","journal-title":"Am J Transl Res"},{"key":"2787_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.wjorl.2018.05.006","volume":"5","author":"TA Janz","year":"2019","unstructured":"Janz TA, Neskey DM, Nguyen SA, Lentsch EJ. Is the incidence of anaplastic thyroid cancer increasing: A population-based epidemiology study. World J Otorhinolaryngol Head Neck Surg. 2019;5:34\u201340. https:\/\/doi.org\/10.1016\/j.wjorl.2018.05.006.","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"2787_CR4","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s00066-022-01943-0","volume":"198","author":"M Schmied","year":"2022","unstructured":"Schmied M, et al. Radio(chemo)therapy in anaplastic thyroid cancer\u2014high locoregional but low distant control rates\u2014a monocentric analysis of a tertiary referral center. Strahlenther Onkol. 2022;198:994\u20131001. https:\/\/doi.org\/10.1007\/s00066-022-01943-0.","journal-title":"Strahlenther Onkol"},{"key":"2787_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13014-023-02249-w","volume":"18","author":"J Jacob","year":"2023","unstructured":"Jacob J, Vordermark D, Lorenz K, Medenwald D. Prognostic factors in radiotherapy of anaplastic thyroid carcinoma: a single center study over 31 years. Radiat Oncol. 2023;18:71. https:\/\/doi.org\/10.1186\/s13014-023-02249-w.","journal-title":"Radiat Oncol"},{"key":"2787_CR6","doi-asserted-by":"publisher","unstructured":"B H. Rapid recurrence of anaplastic carcinoma: advocacy towards non-surgery. Endocrinol Metab Int J. 2017;5. https:\/\/doi.org\/10.15406\/emij.2017.05.00134","DOI":"10.15406\/emij.2017.05.00134"},{"key":"2787_CR7","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/MLG.0b013e3181726d36","volume":"118","author":"AR Shaha","year":"2008","unstructured":"Shaha AR. Airway management in anaplastic thyroid carcinoma. Laryngoscope. 2008;118:1195\u20138. https:\/\/doi.org\/10.1097\/MLG.0b013e3181726d36.","journal-title":"Laryngoscope"},{"key":"2787_CR8","unstructured":"National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology: Thyroid carcinoma [Internet]. 2021 [cited 2025 May 30]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/thyroid.pdf"},{"key":"2787_CR9","doi-asserted-by":"publisher","first-page":"101678","DOI":"10.1016\/j.beem.2022.101678","volume":"37","author":"SN Rao","year":"2023","unstructured":"Rao SN, Smallridge RC. Anaplastic thyroid cancer: an update. Best Pract Res Clin Endocrinol Metab. 2023;37:101678. https:\/\/doi.org\/10.1016\/j.beem.2022.101678.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2787_CR10","doi-asserted-by":"publisher","unstructured":"Bonner AB, Chen H, Spencer SA, Willey CD, Kole AJ. Abstract PO-056: the effect of timing of post-operative radiation on outcomes in anaplastic thyroid cancer. Clin Cancer Res. 2023;29(18Suppl). https:\/\/doi.org\/10.1158\/1557-3265.aacrahns23-po-056.","DOI":"10.1158\/1557-3265.aacrahns23-po-056"},{"key":"2787_CR11","unstructured":"World Health Organization. International classification of diseases for oncology (ICD-O). 3rd ed., 1st revision. Geneva: World Health Organization; 2013."},{"key":"2787_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3656-4","volume-title":"AJCC cancer staging manual","author":"FL Greene","year":"2002","unstructured":"Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.","edition":"6"},{"key":"2787_CR13","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.","edition":"7"},{"key":"2787_CR14","unstructured":"American College of Surgeons. About cancer program categories. Internet. 2023;cited 2025 May 30. Available from: https:\/\/www.facs.org\/quality-programs\/cancer-programs\/commission-on-cancer\/coc-accreditation\/categories\/."},{"key":"2787_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.11138\/gchir\/2018.39.1.005","volume":"39","author":"G Melfa","year":"2018","unstructured":"Melfa G, et al. Surgeon volume and hospital volume in endocrine neck surgery: how many procedures are needed for reaching a safety level and acceptable costs? A systematic narrative review. G Chir. 2018;39:5\u201311. https:\/\/doi.org\/10.11138\/gchir\/2018.39.1.005.","journal-title":"G Chir"},{"key":"2787_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/lary.25606","volume":"126","author":"Z Al-Qurayshi","year":"2016","unstructured":"Al-Qurayshi Z, Randolph GW, Srivastav S, Kandil E. Outcomes in endocrine cancer surgery are affected by racial, economic, and healthcare system demographics. Laryngoscope. 2016;126:775\u201381. https:\/\/doi.org\/10.1002\/lary.25606.","journal-title":"Laryngoscope"},{"key":"2787_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13044-020-00091-w","volume":"13","author":"S De Leo","year":"2020","unstructured":"De Leo S, Trevisan M, Fugazzola L. Recent advances in the management of anaplastic thyroid cancer. Thyroid Res. 2020;13:17. https:\/\/doi.org\/10.1186\/s13044-020-00091-w.","journal-title":"Thyroid Res"},{"key":"2787_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1200\/jop.2016.012013","volume":"12","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas ME, Zafereo M, Gunn GB, Ferrarotto R. Anaplastic thyroid carcinoma: treatment in the age of molecular targeted therapy. J Oncol Pract. 2016;12:511\u20138. https:\/\/doi.org\/10.1200\/jop.2016.012013.","journal-title":"J Oncol Pract"},{"key":"2787_CR19","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/hed.24784","volume":"39","author":"ME Cabanillas","year":"2017","unstructured":"Cabanillas ME, et al. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care. Head Neck. 2017;39:1291\u20135. https:\/\/doi.org\/10.1002\/hed.24784.","journal-title":"Head Neck"},{"key":"2787_CR20","doi-asserted-by":"publisher","unstructured":"Jannin A, et al. Anaplastic thyroid carcinoma: an update. Cancers (Basel). 2022;14. https:\/\/doi.org\/10.3390\/cancers14041061.","DOI":"10.3390\/cancers14041061"},{"key":"2787_CR21","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1530\/ERC-17-0435","volume":"25","author":"V Tiedje","year":"2018","unstructured":"Tiedje V, et al. Anaplastic thyroid carcinoma: review of treatment protocols. Endocr Relat Cancer. 2018;25:R153\u201361. https:\/\/doi.org\/10.1530\/ERC-17-0435.","journal-title":"Endocr Relat Cancer"},{"key":"2787_CR22","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1245\/s10434-015-4742-6","volume":"22","author":"P Goffredo","year":"2015","unstructured":"Goffredo P, Thomas SM, Adam MA, Sosa JA, Roman SA. Impact of timeliness of resection and thyroidectomy margin status on survival for patients with anaplastic thyroid cancer: an analysis of 335 cases. Ann Surg Oncol. 2015;22:4166\u201374. https:\/\/doi.org\/10.1245\/s10434-015-4742-6.","journal-title":"Ann Surg Oncol"},{"key":"2787_CR23","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1001\/jamaoncol.2020.3362","volume":"6","author":"A Maniakas","year":"2020","unstructured":"Maniakas A, et al. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000\u20132019. JAMA Oncol. 2020;6:1397\u2013404. https:\/\/doi.org\/10.1001\/jamaoncol.2020.3362.","journal-title":"JAMA Oncol"},{"key":"2787_CR24","doi-asserted-by":"publisher","unstructured":"Zhou W, Yue Y, Zhang X. Radiotherapy plus chemotherapy leads to prolonged survival in patients with anaplastic thyroid cancer: a retrospective population study. Front Endocrinol (Lausanne). 2021;12. https:\/\/doi.org\/10.3389\/fendo.2021.748023.","DOI":"10.3389\/fendo.2021.748023"},{"key":"2787_CR25","doi-asserted-by":"publisher","first-page":"S1085","DOI":"10.1016\/j.annonc.2020.08.1402","volume":"31","author":"EJ Sherman","year":"2020","unstructured":"Sherman EJ, et al. 1914MO randomized phase II study of radiation therapy and Paclitaxel with pazopanib or placebo: NRG-RTOG 0912. Ann Oncol. 2020;31:S1085. https:\/\/doi.org\/10.1016\/j.annonc.2020.08.1402.","journal-title":"Ann Oncol"},{"key":"2787_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11864-020-00776-2","volume":"21","author":"W Alobuia","year":"2020","unstructured":"Alobuia W, Gillis A, Kebebew E. Contemporary management of anaplastic thyroid cancer. Curr Treat Options Oncol. 2020;21:78. https:\/\/doi.org\/10.1007\/s11864-020-00776-2.","journal-title":"Curr Treat Options Oncol"},{"key":"2787_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/thy.2020.0944","volume":"31","author":"KC Bible","year":"2021","unstructured":"Bible KC, et al. 2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2021;31:337\u201386. https:\/\/doi.org\/10.1089\/thy.2020.0944.","journal-title":"Thyroid"},{"key":"2787_CR28","doi-asserted-by":"publisher","first-page":"e54302","DOI":"10.1371\/journal.pone.0054302","volume":"8","author":"M Ryder","year":"2013","unstructured":"Ryder M, et al. Genetic and Pharmacological targeting of CSF-1\/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression. PLoS ONE. 2013;8:e54302. https:\/\/doi.org\/10.1371\/journal.pone.0054302.","journal-title":"PLoS ONE"},{"key":"2787_CR29","doi-asserted-by":"publisher","first-page":"viii645","DOI":"10.1093\/annonc\/mdy302.002","volume":"29","author":"B Keam","year":"2018","unstructured":"Keam B, et al. Updated efficacy and safety data of Dabrafenib and Trametinib in patients with BRAF V600E\u2013mutated anaplastic thyroid cancer. Ann Oncol. 2018;29:viii645\u20136. https:\/\/doi.org\/10.1093\/annonc\/mdy302.002.","journal-title":"Ann Oncol"},{"key":"2787_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/lary.31712","author":"LK Evans","year":"2024","unstructured":"Evans LK, et al. Improved survival of advanced-stage anaplastic thyroid cancer with systemic therapy. Laryngoscope. 2024. https:\/\/doi.org\/10.1002\/lary.31712.","journal-title":"Laryngoscope"},{"key":"2787_CR31","doi-asserted-by":"publisher","first-page":"764281","DOI":"10.1155\/2014\/764281","volume":"2014","author":"MJ Stavas","year":"2014","unstructured":"Stavas MJ, et al. Short course high dose radiotherapy in the treatment of anaplastic thyroid carcinoma. J Thyroid Res. 2014;2014:764281. https:\/\/doi.org\/10.1155\/2014\/764281.","journal-title":"J Thyroid Res"},{"key":"2787_CR32","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.ijrobp.2004.05.032","volume":"60","author":"R De Crevoisier","year":"2004","unstructured":"De Crevoisier R, et al. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60:1137\u201343. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.05.032.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2787_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.critrevonc.2012.09.007","volume":"86","author":"XS Sun","year":"2013","unstructured":"Sun XS, et al. Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques. Crit Rev Oncol Hematol. 2013;86:52\u201368. https:\/\/doi.org\/10.1016\/j.critrevonc.2012.09.007.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"2787_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/17446651.2025.2467660","volume":"20","author":"A Ullah","year":"2025","unstructured":"Ullah A, et al. Anaplastic thyroid carcinoma: interplay of predictive factors, treatment challenges, and survival insights. Expert Rev Endocrinol Metab. 2025;20(2):129\u201338. https:\/\/doi.org\/10.1080\/17446651.2025.2467660.","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"4","key":"2787_CR35","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1245\/s10434-024-16852-y","volume":"32","author":"K Zhang","year":"2025","unstructured":"Zhang K, et al. Stratified impact of therapies on anaplastic thyroid cancer outcomes in the pre-gene-targeted therapy era. Ann Surg Oncol. 2025;32(4):2732\u201342. https:\/\/doi.org\/10.1245\/s10434-024-16852-y.","journal-title":"Ann Surg Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02787-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:04:59Z","timestamp":1771052699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02787-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2787"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02787-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"At our institution, research involving publicly available datasets do not require institutional review board approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}